FDA Drug Application (021153) for NEXIUM by ASTRAZENECA PHARMS

Back to FDA Applications sponsored by ASTRAZENECA PHARMS

Application Number021153
Product Number001
FormCAPSULE, DELAYED REL PELLETS;ORAL
DosageEQ 20MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameNEXIUM
Active IngredientESOMEPRAZOLE MAGNESIUM

Active IngredientCount
List of drugs with Active Ingredient ESOMEPRAZOLE MAGNESIUM5


Back to FDA Applications sponsored by ASTRAZENECA PHARMS